Mohs Micrographic Surgery in Skin of Color

J Drugs Dermatol. 2022 May 1;21(5):536-541. doi: 10.36849/JDD.6469.

Abstract

The United States population is becoming increasingly diverse. Data show increased utilization of Mohs micrographic surgery (MMS) in people of color. Though the incidence of skin cancer in skin of color is low, morbidity and mortality are disproportionately high. Still, published literature on the topic is lacking. In this article, we outline our approach to MMS in skin of color. We review salient topics not published elsewhere in literature in this context, including post-operative postinflammatory hyperpigmentation and suture selection in skin of color. Our goal is to better equip dermatologic surgeons for the rapidly changing demographics of our patient population. We feel this is an important step in addressing the dire health disparities associated with skin cancer in skin of color. J Drugs Dermatol. 2022;21(5):536-541. doi:10.36849/JDD.6469.

Publication types

  • Review

MeSH terms

  • Ethnic and Racial Minorities
  • Humans
  • Incidence
  • Mohs Surgery*
  • Skin
  • Skin Neoplasms* / ethnology
  • Skin Neoplasms* / surgery
  • United States